Novo Nordisk invests GBP 115m in British research center

Novo Nordisk is establishing a new research center at the University of Oxford and has struck a deal with the university for the discovery of innovative approaches for treating type 2 diabetes. The company is dedicating 100 scientists and GBP 115 million to the project.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Reuters: Kinesere vil købe J&J's diabetesforretning

Amerikanske Johnson & Johnson kan være på vej til at sælge sin forretning for diabetesudstyr for godt 24 mia. kr., efter flere kinesiske aktører ifølge Reuters har vist interesse i at overtage forretningsdelen.

Related articles